FDA Inspection 938778 — DoubleDay Acquisitions

DoubleDay Acquisitions — FEI 3009134624

The FDA completed an inspection of DoubleDay Acquisitions on August 4, 2015 in Monroe, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 9 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 4, 2015
Fiscal Year
2015
Product Type
Devices
Project Area
Compliance: Devices
Location
Monroe, OH (United States)

Citations

IDCFRDescription
243021 CFR 820.30(b)Design plans - Lack of or inadequate
255721 CFR 820.30(c)Design input - documentation
263021 CFR 820.30(e)Design review - documentation
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
311821 CFR 820.75(a)Documentation
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
319121 CFR 820.30(g)Design validation - production units
367421 CFR 820.30(d)Design output - documentation
367621 CFR 820.30(f)Design verification - documentation